Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on PRA Health Sciences Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 15 Nov 2022 | Eli Lilly and Co Enters Phase I Clinical Trial Agreement with PRA Health Sciences Inc for LY-3556050 (GDCT0471925) | Contract Service Agreement |
Eli Lilly and Co
Eli Lilly and Co Eli Lilly and Co |
PRA Health Sciences Inc PRA Health Sciences Inc PRA Health Sciences Inc |
| 08 Nov 2022 | Boehringer Ingelheim International GmbH Enters Phase I Clinical Trial Agreement with PRA Health Sciences Inc for brigimadlin (GDCT0471931) | Contract Service Agreement |
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH |
PRA Health Sciences Inc PRA Health Sciences Inc PRA Health Sciences Inc PRA Health Sciences Inc PRA Health Sciences Inc |
| 17 Oct 2022 | Pfizer Inc Enters Phase I Clinical Trial Agreement with PRA Health Sciences Inc for PF-07261271 (GDCT0466137) | Contract Service Agreement |
Pfizer Inc
|
PRA Health Sciences Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer